BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35617843)

  • 1. Generation of a human extended pluripotent stem cell line (SKLRMe002-A) carrying a doxycycline-inducible Cas9 expression cassette.
    He Z; Feng K; Sun H; Yu T; Zhu D; Yang Y
    Stem Cell Res; 2022 Jul; 62():102816. PubMed ID: 35617843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
    Gu J; Rollo B; Sumer H; Cromer B
    Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the "safe harbor" AAVS1 locus.
    Castaño J; Bueno C; Jiménez-Delgado S; Roca-Ho H; Fraga MF; Fernandez AF; Nakanishi M; Torres-Ruiz R; Rodríguez-Perales S; Menéndez P
    Stem Cell Res; 2017 May; 21():137-140. PubMed ID: 28677529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human embryonic stem cell line (SMUDHe010-A-1A) carrying Brainbow cassette in the AAVS1 gene by CRISPR/Cas9-mediated homologous recombination.
    Luo Y; Zheng W; Zhong Y; Liu H; Yu J; Qiu B; Liu J; Yang B
    Stem Cell Res; 2024 Jun; 77():103383. PubMed ID: 38507883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.
    Guo J; Ma D; Huang R; Ming J; Ye M; Kee K; Xie Z; Na J
    Protein Cell; 2017 May; 8(5):379-393. PubMed ID: 28116670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of three isogenic gene-edited Huntington's disease human embryonic stem cell lines with DOX-inducible NGN2 expression cassette in the AAVS1 safe locus.
    Villegas LD; Chandrasekaran A; Andersen SAF; Nørremølle A; Schmid B; Pouladi MA; Freude K
    Stem Cell Res; 2024 Jun; 77():103408. PubMed ID: 38569398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
    Matsunaga T; Yamashita JK
    Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
    Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
    Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology.
    Zhang D; Zhou M; Zhang Y; Shan Y; Pan G
    Stem Cell Res; 2022 Jul; 62():102809. PubMed ID: 35567848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining a tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC).
    Priesmeier L; Schoger E; Cyganek L; Cecilia Zelarayán L
    Stem Cell Res; 2023 Sep; 71():103163. PubMed ID: 37433260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease.
    Jung J; Hwang S; Seol H; Kim AH; Lee HM; Sung JJ; Jeong SM; Choi YM; Jun JK; Kim DW; Jang J
    Stem Cell Res; 2021 May; 53():102321. PubMed ID: 33878708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human embryonic stem cell line (SMUDHe010-A-1B) carrying inducible DTA expression cassette in the AAVS1 locus by CRISPR/Cas9-mediated homologous recombination.
    Qiu B; Zheng W; Zhong Y; Liu H; Yu J; Luo Y; Liu J; Yang B
    Stem Cell Res; 2024 Feb; 74():103283. PubMed ID: 38103335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression.
    Liu Y; Wu F; Liu D; Wei R; Abbas N; Xia J; Li D; Wang H; Zhuang Y; Guo D; Chen Y; Wu Y; Ke X; Tao J; Yang F; Lai K; Shu X; Li YX
    Stem Cell Res; 2018 May; 29():84-87. PubMed ID: 29627726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a gene-edited H9 embryonic stem cell line carrying a DOX-inducible NGN2 expression cassette in the CLYBL locus.
    Miellet S; St Clair-Glover M; Maddock M; Dottori M
    Stem Cell Res; 2024 Mar; 75():103312. PubMed ID: 38244534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.
    Ferreccio A; Mathieu J; Detraux D; Somasundaram L; Cavanaugh C; Sopher B; Fischer K; Bello T; M Hussein A; Levy S; Cook S; Sidhu SB; Artoni F; Palpant NJ; Reinecke H; Wang Y; Paddison P; Murry C; Jayadev S; Ware C; Ruohola-Baker H
    Cell Cycle; 2018; 17(5):535-549. PubMed ID: 29466914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of TUBB3-mCherry knock-in human pluripotent stem cell line using CRISPR/Cas9 (SNUe003-A-4).
    Kim AH; Lee HM; Kim HS; Jung J; Seol H; Choi E; Lee S; Min Choi Y; Jun JK; Kim HS; Jang J
    Stem Cell Res; 2023 Jun; 69():103064. PubMed ID: 36913849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an Akaluc knock-in human embryonic stem cell reporter line using CRISPR-Cas9 technology.
    Zhou M; Xing Q; Zhang D; Zhang C; Zhang Y; Zhang J; Shan Y
    Stem Cell Res; 2021 Oct; 56():102532. PubMed ID: 34509917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a dual edited human induced pluripotent stem cell Myl7-GFP reporter line with inducible CRISPRi/dCas9.
    Metzl-Raz E; Bharucha N; Arthur Ataam J; Gavidia AA; Greenleaf WJ; Karakikes I
    Stem Cell Res; 2022 May; 61():102754. PubMed ID: 35325819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
    Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation.
    Schoger E; Argyriou L; Zimmermann WH; Cyganek L; Zelarayán LC
    Stem Cell Res; 2020 Oct; 48():101944. PubMed ID: 33038615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.